GlassScriptPhysician profile
Bradley D Noblett
NPI 1689788507
$2,443.52
in general payments reported to CMS, 2019-2025
16 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $186 · 2021: $728 · 2022: $474 · 2023: $288 · 2024: $76.50 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $967.85 | 2019-2025 | Affirm, Stretto, Kinex |
| Nuvasive, INC. | $352.84 | 2019-2023 | Pulse, Tlx |
| Depuy Synthes Sales INC. | $297.77 | 2019-2022 | |
| Integra Lifesciences Corporation | $264.60 | 2019-2022 | |
| Nevro Corp. | $119.21 | 2019-2022 | |
| Stryker Corporation | $83.21 | 2019-2025 | Universal Neuro 3, Hydroset |
| Spineart USA INC | $81.27 | 2023 | Perla Tl |
| Spineology INC. | $54.34 | 2020-2022 | |
| Monteris Medical Corporation | $46.44 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $45.49 | 2019 | |
| Medtronic, INC. | $42.57 | 2022-2023 | Infinity Occipitocervical Upper Thoracic System |
| Biocomposites INC | $27.92 | 2024 | |
| Abbvie INC. | $25.37 | 2023 | |
| Titan Spine, LLC | $20.55 | 2019 | |
| Valinor Pharma, LLC | $14.09 | 2023 | Movantik |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Noblett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.